scholarly journals Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Taoufik Alsaadi ◽  
Khadija El Hammasi ◽  
Tarek M. Shahrour ◽  
Mustafa Shakra ◽  
Lamya Turkawi ◽  
...  
Keyword(s):  
Major Depression ◽  
Cross Sectional Study ◽  
Screening Tools ◽  
Depression And Anxiety ◽  
Cross Sectional ◽  
East Region ◽  
Prevalence Of Depression ◽  
Medical City ◽  
Standardized Screening ◽  
Middle East Region

Depression and anxiety are reported to be prevalent in patients with MS, with prevalence rates ranging from 20% to 50%. Unfortunately, the rates, patterns, and risk factors are not well studied in our Middle East region, and, to our knowledge, not at all in UAE. Using standardized screening tools, we observed that 17% and 20% of 80 patients seen in MS clinic had scores consistent with major depression and anxiety disorders, respectively, at a rate that was not statistically different when compared to age and sex matched controls. None of the studied variables including duration of the disease, EDSS scores, age, gender, and the level of education had any significant correlation with the rates of both disorders. Almost two-thirds of the patients with scores consistent with major depression and anxiety were not on antidepressant and antianxiety medications.

scholarly journals Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Mohammed Hammoudeh ◽  
Hanan Al Rayes ◽  
Adel Alawadhi ◽  
Kamel Gado ◽  
Khalid Shirazy ◽  
...  
Keyword(s):  
Middle East ◽  
Disease Burden ◽  
Clinical Laboratory ◽  
Management Strategies ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
East Region ◽  
Appropriate Treatment ◽  
Treatment Data ◽  
Middle East Region

Data on spondyloarthritis (SpA) from the Middle East are sparse and the management of these diseases in this area of the world faces a number of challenges, including the relevant resources to enable early diagnosis and referral and sufficient funds to aid the most appropriate treatment strategy. The objective was to report on the characteristics, disease burden, and treatment of SpA in the Middle East region and to highlight where management strategies could be improved, with the overall aim of achieving better patient outcomes. This multicenter, observational, cross-sectional study collected demographic, clinical, laboratory, and treatment data on 169 consecutive SpA patients at four centers (Egypt, Kuwait, Qatar, and Saudi Arabia). The data collected presents the average time from symptom onset to diagnosis along with the presence of comorbidities in the region and comparisons between treatment with NSAIDs and biologics. In the absence of regional registries of SpA patients, the data presented here provide a rare snapshot of the characteristics, disease burden, and treatment of these patients, highlighting the management challenges in the region.

Depression and Anxiety in Patients with Chronic Renal Failure Undergoing Hemodialysis

2021 ◽  
Author(s):  
Elham Shahraki ◽  
Mansoor Shakiba ◽  
Seyedeh Yasaman Ghasemi-Aliabadi
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Rating Scale ◽  
Cross Sectional Study ◽  
Hemodialysis Patients ◽  
Depression And Anxiety ◽  
Mild Depression ◽  
Cross Sectional ◽  
Prevalence Of Depression ◽  
High Level

Background: Chronic renal failure is a disabling condition with multiple complication such as depression and anxiety; they are common in hemodialysis patients and have negatively effect on quality of life. In this study we investigate the prevalence of depression and anxiety in Zahedan hemodialysis patients. Methods: A total 200 patients undergoing regular hemodialysis for more than six months included in this descriptive cross-sectional study. After consent The Hamilton Rating Scale for Depression and anxiety (HAM-D7) in a version translated into and adapted to Persian, were used. Results: The patients median age was (43.06 ± 16.11) years and 38.5% was male. Mild depression was observed in (15) 7.5%, moderate in (81) 40.5% and sever depression in (104) 52% of patients. In this study 19.5% (39) of patients has moderate anxiety and 80.5% (161) patients with sever anxiety. A significant correlation was found between duration of dialysis, older age and depression. But there wasn’t any relationship between age and duration of dialysis with anxiety. Anxiety and depression found without any significant differences in both males and females. Conclusion: We found high level of depression an anxiety in Zahedan hemodialysis patients.

Assessment of Factors Associated with Depression and Anxiety Among pwMS in Saudi Arabia

2021 ◽  
Author(s):  
Saffanah Alsaeed ◽  
Nuha Alkhawajah ◽  
Salman Aljarallah ◽  
Rola Alarieh ◽  
Amani Abushaheen
Keyword(s):  
Saudi Arabia ◽  
Physical Inactivity ◽  
Depression Scale ◽  
Sampling Technique ◽  
Simple Random Sampling ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Cross Sectional ◽  
Medical City

Abstract Background. Multiple sclerosis (MS) is an inflammatory chronic disease that is characterized by an increased prevalence of adverse mental health outcomes in patients with MS (pwMS). The main aim of this study is to investigate the factors of depression and anxiety in pwMS in the Kingdom of Saudi Arabia (KSA). Materials and Methods. This is a cross-sectional study conducted in KSA during the period from March to June 2020. Participants were recruited from the Neuroimmunology clinics in King Fahad Medical City (KFMC) and King Saud University medical city (KSUMC)in Riyadh City, KSA. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety. Fatigue Severity Scale (FSS) was used to measure fatigue in pwMS. A simple random sampling technique was utilized to select participants and the data were analyzed using SPSS v.24.0. Results. A total of 529 participants participated in this study with a response rate of 53.1%. The prevalences of anxiety and depression were 35.3% and 19.7%, respectively. The findings also revealed that depression was more likely to be significantly affected by being male, low education, unemployment, physical inactivity, and fatigue but the anxiety was significantly affected by region, unemployment, short duration since last MS relapse, physical inactivity, and fatigue. Conclusion. Anxiety and depression are not uncommon in pwMS. Given their impact on the lives of affected patients, early detection and management of these symptoms and their associated factors are crucial.

scholarly journals The Prevalence of Depression and Anxiety Disorders Among Postgraduate Students in an Arabic Sample: A Cross-sectional Study

2021 ◽  
Author(s):  
Asem A. Alageel ◽  
Rayyan A. Alyahya ◽  
Raed A Alghamdi ◽  
Ban A. Alzaid ◽  
Aryaf. S Alsubaie ◽  
...  
Keyword(s):  
Mental Health ◽  
Anxiety Disorders ◽  
Online Survey ◽  
Cross Sectional Study ◽  
Depression And Anxiety ◽  
Cross Sectional ◽  
Postgraduate Students ◽  
High Prevalence ◽  
Prevalence Of Depression ◽  
Patient Health

Abstract Background: Depression and anxiety are indicators of mental health and quality of life. Studies found a high prevalence of depression and anxiety disorders among specific populations, such as medical students, residents and fellows. However, postgraduate students unarguably suffer from many private and career life stressors. Unfortunately, research about the prevalence of depression and anxiety among postgraduate students are greatly lacking.Methods: A cross-sectional online survey; a self-questionnaire divided into five sections. Socio-demographic characteristics, the Patient Health Questionnaire for Depression (PHQ9), Generalized Anxiety Disorder 7 item (GAD7), insomnia and suicide. Results: The number of participants was 1,005, The prevalence of depression and GAD that warrant treatments are 27.4% and 23.6%, respectively. Most of the participants who screened positive for depression and GAD were not aware of having these disorders. Females were at a higher risk of depression (OR: 1.5, 95% CL: 1.10 to 2.15) and GAD (OR:1.49, 95% CL 1.07 to 2.07). Insomnia is associated significantly with depression (P<0.001) and GAD (P<0.001). Depression increases the risk for active suicide thoughts (OR= 7.453) (P<0.001). Limitations: Due to the nature of cross-sectional studies, causal relationships cannot be identified.Conclusion: We have identified a higher prevalence of depression and GAD among postgraduate students compared with the general population. However, they appear to be underrepresented in mental health literature, so further research is necessary.

scholarly journals Prevalence of Depression, Anxiety and Cognitive Impairment in Patients with Type 2 Diabetes from the Central Part of Romania

2016 ◽  
Vol 62 (2) ◽  
pp. 209-216 ◽  
Author(s):  
Simona Cernea ◽  
Cristian Zoltai ◽  
Daniela Berbecilă ◽  
Floredana-Laura Şular
Keyword(s):  
Type 2 Diabetes ◽  
Cognitive Impairment ◽  
Severe Depression ◽  
Cross Sectional Study ◽  
Depression And Anxiety ◽  
Cross Sectional ◽  
Prevalence Of Depression ◽  
Screening Study ◽  
Highly Correlated

AbstractObjective: The aim of this study was to assess the prevalence of depression, anxiety and cognitive impairment in patients with type 2 diabetes (T2D).Material and methods: We conducted a cross-sectional study in patients with T2D. Depression and anxiety were assessed by questionnaires (PHQ-9, CES-D and GAD-7 respectively), cognitive function by the MoCA test. Additionally, 503 patients’ clinic charts were separately analyzed in order to compare the data recorded in the charts with that resulted from the active assessment.Results: In the screening study 216 subjects with T2D were included (62.2 ± 7.8 years old). 34.3% of them had depression and 7.4% presented major depression. 44.9% of patients with T2D had anxiety (9.2% major anxiety) and this was highly correlated with depression (OR: 21.139, 95%CI: 9.767-45.751; p<0.0001). Women had significantly higher prevalence of depression and anxiety compared to men (42.1% vs. 21.7%; p: 0.0021 and 51.1% vs. 34.9%; p: 0.02), but severe depression was similar between genders (9.0% vs. 4.8%; p: 0.29). Significantly more patients had depression and anxiety than recorded in their charts (34.3% vs. 13.9% and 44.9% vs. 9.3%, respectively; p<0.0001 for both). 69.0% of T2D patients had mild, 6.0% had moderate and none had severe cognitive dysfunction, respectively. Significantly more patients with depression and anxiety had mild and moderate cognitive impairment (p: 0.03 and p: 0.04, respectively).Conclusions: Patients with T2D had a high prevalence of comorbid depression, anxiety and cognitive impairment. Depression and anxiety were significantly more frequent in women. These conditions were under-evaluated and/or under-reported.

scholarly journals Prevalence of depression and anxiety among male patients with COVID-19 in Lebsayyer Field Hospital, Qatar

2021 ◽  
Vol 2021 (3) ◽  
Author(s):  
Nashwan Zainal Deen ◽  
Amr Al-Sharafi ◽  
Mohamed Abdalla ◽  
Mohammed Mushtaha ◽  
Ahmad Mohamed ◽  
...  
Keyword(s):  
Substantial Effect ◽  
Anxiety Symptoms ◽  
Screening Tools ◽  
World Health ◽  
Depression And Anxiety ◽  
Field Hospital ◽  
Cross Sectional ◽  
Asian Ethnicity ◽  
Prevalence Of Depression ◽  
Male Patients

Background: Depression and anxiety are major health problems found to be associated with various conditions. COVID-19 is a global pandemic that has a substantial effect on the worldwide population. This study aimed to assess the prevalence of depression and anxiety among male patients with COVID-19 and explore their relationship with participants’ characteristics. Methods: This cross-sectional study was conducted among expatriate male patients with COVID-19 admitted to Lebsayyer Field Hospital in Qatar with mild COVID-19 (according to World Health Organization classification) from July till August 2020. The sample size was calculated using Cochran's formula based on disease prevalence. All eligible patients were invited to participate until reaching 400 participants, who then completed an anonymous survey of sociodemographic questions, Patient Health Questionnaire-9, and Generalized Anxiety Disorder-7 questionnaire, which are validated screening tools for depression and anxiety, respectively. Results: Of the 400 participants, 148 (37.0%) and 77 (19.3%) reported depressive and anxiety symptoms, respectively. Depression was more prevalent among those 40–49 years old (p = 0.029), while anxiety was more prevalent among people aged  ≥ 50 (p = 0.456). Both depression (p = 0.009) and anxiety (p = 0.042) were more prevalent among Bangladeshi, followed by Filipino participants. Depression was more prevalent among those with the highest income (> 15,000 QR; p = 0.004), in contrast to anxiety, which was more prevalent among those with the lowest monthly income ( <  2,000 QR; p = 0.039). Conclusion: The prevalence of depressive and anxiety symptoms is high among the study participants. Associated factors identified by the study were unsteady income, poor self-rated health, living with family, Southeast Asian ethnicity, and age group of 40–49 years.

Sign in / Sign up

Export Citation Format

Share Document